Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesWages, Salaries and Other
Ratios

Coeptis Therapeutics Holdings (COEP) Shares Issued (2022 - 2025)

Historic Shares Issued for Coeptis Therapeutics Holdings (COEP) over the last 4 years, with Q3 2025 value amounting to $3.0 million.

  • Coeptis Therapeutics Holdings' Shares Issued changed N/A to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 24819.84%. This contributed to the annual value of $500000.0 for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Shares Issued of $3.0 million as of Q3 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Shares Issued peaked at $3.0 million during Q3 2025, and registered a low of -$2.5 million during Q4 2023.
  • In the last 4 years, Coeptis Therapeutics Holdings' Shares Issued had a median value of $300000.0 in 2023 and averaged $435518.4.
  • Data for Coeptis Therapeutics Holdings' Shares Issued shows a peak YoY increase of 9242.42% (in 2023) and a maximum YoY decrease of 25409360000.0% (in 2023) over the last 5 years.
  • Quarter analysis of 4 years shows Coeptis Therapeutics Holdings' Shares Issued stood at $1.0 in 2022, then crashed by 254093600.0% to -$2.5 million in 2023, then surged by 119.68% to $500000.0 in 2024, then soared by 504.83% to $3.0 million in 2025.
  • Its Shares Issued stands at $3.0 million for Q3 2025, versus $100.0 for Q2 2025 and $400.0 for Q1 2025.